강현재 교수
Hyun-Jae Kang
서울대학교 · 의학
연구실 소개
강현재 교수의 연구실은 심혈관 질환, 특히 급성 심근경색 환자를 대상으로 한 줄기세포 치료의 임상적 적용과 기전 규명을 핵심으로 삼고 있습니다. 특히 혈액으로 유도된 혈액줄기세포와 유도만능줄기세포에서 유래한 간엽줄기세포의 면역학적 안정성과 심장세포로의 분화 능력을 중심으로 연구를 진행하고 있으며, 스텐트 이식 후 재혈전성 위험을 줄이기 위한 약물 조절 전략도 함께 탐색하고 있습니다. 이들의 연구는 임상 적용에 가까운 실용적이고 안전한 줄기세포 치료 전략 개발을 목표로 하고 있습니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15Intracoronary infusion of mobilized PBSCs with G-CSF improves LVEF and remodeling in patients with AMI but is less definite in patients with OMI. G-CSF-based stem cell therapy with DES implantation is both feasible and safe, eliminating any potential for restenosis.
We observed consistency of effects in Asian patients receiving ticagrelor and clopidogrel in the PLATO study. The relatively modest number of Asian patients in this analysis supports further investigation of larger cohorts to confirm our observations.
Application of human embryonic stem cells (hESCs) to stem-cell therapy is not feasible because of the risk of tumorigenicity and rejection. In contrast, human mesenchymal stem cells (hMSCs) are free from the risk of tumorigenicity and also have immune privilege. However, hMSCs obtained from adults have infinite variety in terms of the biological characteristics and functionality. We report here a new derivation method of hMSCs from hESCs. The derivation of hMSCs from three different hESC lines (
Stem cell transplantation in acute myocardial infarction (AMI) has emerged as a promising therapeutic option. We evaluated the impact of AMI on mesenchymal stem cell (MSC) differentiation into cardiomyocyte lineage. Cord blood-derived human MSCs were exposed to in vitro conditions simulating in vivo environments of the beating heart with acute ischemia, as follows: (a) myocardial proteins or serum obtained from sham-operated rats, and (b) myocardial proteins or serum from AMI rats, with or witho
Peripheral blood stem cell therapy has potential to improve long-term cardiovascular outcomes in MI patients.
Three-month adjunctive celecoxib would be useful to reduce LL of DES. However, this study may raise the concern about increased thrombotic risk with celecoxib even in patients receiving dual anti-platelet therapy.
Reduced FEV1%, which represents the severity of airway obstruction, was associated with chronic AF, and the greater the pulmonary function impairment, the greater the co-existence with AF and congestive heart failure in those with preserved left ventricular systolic function.
Acquisition of pre-beamformed data is essential in advanced imaging research studies such as adaptive beamforming, synthetic aperture imaging, and photoacoustic imaging. Ultrasonix Co. has developed such a data acquisition device for pre-beamformed data known as the SONIX-DAQ, but data can only be downloaded and processed offline rather than streamed in real-time. In this work, we developed a software framework to extend the functionality of the SONIX-DAQ for streaming and processing data in nea
Iloprost infusion increased SMA blood flow by 60% in this model of nonocclusive mesenteric ischemia (from 168 +/- 41 to 269 +/- 76 mL/min; p <.05). The effect of iloprost infusion was more prominent after the tamponade (422 +/- 87 mL/min in the iloprost group vs. 232 +/- 111 mL/min in the control group; p <.05). Increased mesenteric perfusion decreased intestinal mucosal hypercarbia, leading to improvement of intramucosal pH.
MP transfer with magnet application can be a promising novel strategy to enhance homing efficacy and outcomes of current stem cell therapy.
대표 연구 분야
강현재 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.